MedPredict
MedPredict Thought Leader Insight
User ID:
Password:
  For Pharma and Biotech Decision-Makers LATEST PUBLICATIONS  

One of your key challenges is to stay on top of the latest activities in your target therapeutic areas. What’s happening with competitive compounds in the pipeline? What are their indications and marketing claims likely to be? How are trends in clinical practice evolving, and how will that affect your current and future business?

MedPredict delivers the insights that will drive your strategic decision-making, but without the big price tag and long lead-time required to conduct your own thought leader interviews or market research. We deliver a wide range of syndicated reports that are ready to download today, so you can act on the information right away. And if you don't see what you need in our syndicated reports database, we would be happy to provide you with a customized proposal for proprietary research.

Browse our site to see how MedPredict can provide the thought leader insight you need to make breakthrough strategic decisions.

Reports Coming Soon...

Lymphomas -- Post-ASH

MDS/AML -- Post-ASH
Antithrombotics/Antiplatelets -- Post-ASH

Breast Cancer -- Post-SABCS

Psoriasis
Diabetes
Obesity


New therapeutic area -- HIV

Upcoming Events...

Breast Cancer This new report provides a post-San Antonio Breast Cancer Symposium thought leader debrief. Some of the topics discussed by our panel include: Bone active agents for the prevention or treatment of skeletal related events associated with breast cancer or its treatment, bold trial designs, new HER2 agents, new mechanisms, and more. learn more >>

Osteoporosis For this report we conducted primary interviews with six global osteoporosis thought leaders. They provide insight into anabolics, antiresorptives and steroids for glucocorticoid induced osteoporosis, bisphosphonates and transverse femoral shaft fractures, positioning of denosumab vs. zoledronic acid, and much more. learn more >>

RA, Lupus, Gout Following the recent ACR meeting we debriefed with a panel of global rheumatology thought leaders (3 North American, 3 European). Based on these discussions, we provide a thorough review of the pipelines for RA, Lupus and gout, as well as insightful analysis of unmet needs. learn more >>

Respiratory Post-ERS Debrief We discuss the latest developments in Asthma, COPD and Rhinitis with European and North American thought leaders following the recent ERS conference. learn more >>

 
bottom.gif